A surge of frustration continues to shake forums as holders of CRO express their discontent with the recent unburn decision by Coin Development Company (CDC). Despite a slight price recovery, a significant portion of the community remains skeptical about CDC's management and direction.
The unburn announcement triggered intense discussions, with users questioning the integrity of tokenomics and governance. Many are linking their discord to previous issues like the MCO token swap, leaving some feeling that forgiving CDC will take time.
Users remain critical of the 233% increase in token supply, fearing it threatens decentralization. A user encapsulated the sentiment with: "They just manipulated the price down then back up slightly. The sell pressure at 16-20 cents will be insane if it ever gets there." This sentiment reflects a deep-rooted distrust in CDCβs motives, leading many to speculate about the future value of CRO.
Comments highlight growing frustrations regarding CDC's governance, with phrases such as "Itβs just a voucher for CDC to do whatever it wants" surfacing. Some believe a significant portion of the community is only holding out to break even on their investments. One user noted, "I sold all my CRO at a huge loss and moved on. It is what it is." Such perspectives underline the continuation of a negative sentiment toward CDC's handling of user concerns.
Despite the discontent, some users point out that CRO still holds decent utility with the cards, calling it a unique selling proposition. "You donβt need to be paid by CDC to see those benefits," stated a defender of the utility, suggesting that thereβs more to the token than just its price performance.
"People on here are still salty about the MCO token swap, so probably not any time soon," remarked another forum commenter, illustrating the ongoing bitterness that lingers among the community.
πΊ 233% increase in token supply drawing widespread concern.
π¬ "They just manipulated the price down then back up slightly" - User comment reflecting skepticism.
π« Ongoing discontent and unresolved issues may hinder future investments in CRO.
βοΈ Some users believe in the utility of CRO despite the controversies.
As frustration continues to boil, CDC faces the challenge of regaining the trust of its community. The coming weeks will be critical to see if management will adjust its strategies in response to the rising dissatisfaction among holders. Will CDC find a path back to user confidence, or will it succumb to the pressures festering in the forums?